Inspire Medical Systems (NYSE:INSP) Now Covered by KeyCorp

Stock analysts at KeyCorp began coverage on shares of Inspire Medical Systems (NYSE:INSPGet Free Report) in a report released on Tuesday, Benzinga reports. The brokerage set an “overweight” rating and a $278.00 price target on the stock. KeyCorp’s price objective points to a potential upside of 28.57% from the company’s previous close.

A number of other brokerages also recently weighed in on INSP. JPMorgan Chase & Co. cut their price target on shares of Inspire Medical Systems from $340.00 to $181.00 and set an “overweight” rating on the stock in a report on Tuesday, October 17th. Truist Financial upped their price objective on shares of Inspire Medical Systems from $240.00 to $260.00 and gave the company a “buy” rating in a report on Friday, December 22nd. Stifel Nicolaus reaffirmed a “hold” rating and set a $210.00 price objective on shares of Inspire Medical Systems in a report on Tuesday, January 2nd. Mizuho lowered their price target on shares of Inspire Medical Systems from $300.00 to $215.00 and set a “buy” rating on the stock in a report on Wednesday, November 8th. Finally, TheStreet downgraded shares of Inspire Medical Systems from a “c-” rating to a “d+” rating in a report on Thursday, October 26th. Four research analysts have rated the stock with a hold rating and nine have issued a buy rating to the stock. According to data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $268.69.

Get Our Latest Report on Inspire Medical Systems

Inspire Medical Systems Stock Performance

Shares of NYSE:INSP opened at $216.23 on Tuesday. The company’s 50-day moving average is $187.56 and its 200 day moving average is $194.97. The company has a market capitalization of $6.38 billion, a P/E ratio of -191.35 and a beta of 1.42. Inspire Medical Systems has a fifty-two week low of $123.27 and a fifty-two week high of $330.00.

Inspire Medical Systems (NYSE:INSPGet Free Report) last issued its quarterly earnings results on Tuesday, November 7th. The company reported ($0.29) earnings per share for the quarter, topping analysts’ consensus estimates of ($0.53) by $0.24. The company had revenue of $153.30 million for the quarter, compared to the consensus estimate of $154.49 million. Inspire Medical Systems had a negative net margin of 5.75% and a negative return on equity of 6.32%. The firm’s quarterly revenue was up 40.4% on a year-over-year basis. During the same period in the previous year, the firm earned ($0.60) EPS. As a group, research analysts predict that Inspire Medical Systems will post -1.26 earnings per share for the current year.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently bought and sold shares of INSP. FMR LLC grew its position in Inspire Medical Systems by 130.1% during the third quarter. FMR LLC now owns 2,471,464 shares of the company’s stock valued at $490,437,000 after acquiring an additional 1,397,510 shares during the last quarter. Baillie Gifford & Co. boosted its stake in shares of Inspire Medical Systems by 6,846.9% during the fourth quarter. Baillie Gifford & Co. now owns 1,229,879 shares of the company’s stock valued at $250,194,000 after purchasing an additional 1,212,175 shares during the period. Wellington Management Group LLP boosted its stake in shares of Inspire Medical Systems by 72.8% during the third quarter. Wellington Management Group LLP now owns 976,972 shares of the company’s stock valued at $193,870,000 after purchasing an additional 411,480 shares during the period. Jennison Associates LLC boosted its stake in shares of Inspire Medical Systems by 648.2% during the fourth quarter. Jennison Associates LLC now owns 304,886 shares of the company’s stock valued at $62,023,000 after purchasing an additional 264,139 shares during the period. Finally, Norges Bank purchased a new stake in shares of Inspire Medical Systems during the fourth quarter valued at approximately $65,929,000. 94.91% of the stock is currently owned by institutional investors.

Inspire Medical Systems Company Profile

(Get Free Report)

Inspire Medical Systems, Inc, a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe OSA.

Featured Stories

Analyst Recommendations for Inspire Medical Systems (NYSE:INSP)

Receive News & Ratings for Inspire Medical Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Inspire Medical Systems and related companies with MarketBeat.com's FREE daily email newsletter.